Early Life
Mahima Datla's career in the pharmaceutical industry began after she graduated from Webster University, London, with a Bachelor's degree in Business Administration Management. She joined Biological E. Limited in 2001, a company founded by her grandfathers.
Rise to Success
Datla's career progressed steadily within Biological E. Limited. She was appointed Managing Director in 2013. Under her leadership, the company has expanded its vaccine portfolio, with a focus on global health initiatives and partnerships with international organizations like WHO and UNICEF. She has been instrumental in Biological E.’s push to create and deliver vaccines to combat diseases, most notably the COVID-19 vaccine, Corbevax.
Key Business Strategies
Datla has focused on a few key strategies, including the diversification of the company's vaccine portfolio, strategic partnerships, and investments in research and development. Biological E. Limited has also expanded its production capacity and distribution networks to reach more countries and populations. Datla has overseen Biological E.'s expansion into specialty generic injectables and branded formulations, enhancing its market presence.
Philanthropy
Datla is involved with the Sadhikaratha Foundation, and has also served on the board of the Global Health Innovative Technology fund. Biological E. Limited's mission is to improve health and survival and contribute to societies by providing equitable access to quality vaccines.